Quantbot Technologies LP Prelude Therapeutics Inc Transaction History

Quantbot Technologies LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$4.61 - $8.5 $2,766 - $5,100	-600 Reduced 42.86%	800 $4,000
Q3 2022 Nov 07, 2022	SELL	$5.0 - $8.82 $7,000 - $12,348	-1,400 Reduced 50.0%	1,400 $9,000
Q2 2022 Aug 09, 2022	BUY	$4.0 - $7.55 $11,200 - $21,140	2,800 New	2,800 $14,000
Q1 2022 May 16, 2022	SELL	$6.9 - $13.22 $56,580 - $108,404	-8,200 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$11.89 - $31.74 $95,120 - $253,920	8,000 Added 4000.0%	8,200 $102,000
Q3 2021 Nov 09, 2021	BUY	$25.78 - $38.65 $5,156 - $7,730	200 New	200 $6,000

35.9M

500

300

Ticker PRLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,369,200
Market Cap $42.6M
Description
Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid ...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.